AzTrials
AzTrials

Thyroglossal CystNCT07778485

Study on the Efficacy of Laparoscopic-Assisted Thyroglossal Duct Cyst Resection Via Submental Approach

A study testing The experimental group in people with Thyroglossal Cyst, run by People's Hospital of Anshun City of Guizhou Province.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Thyroglossal duct cysts are congenital diseases of the neck. Once detected, surgical treatment is the first choice. The traditional Sistrunk surgery has definite efficacy but leaves scars on the neck. Read more about this study

Who is it for?
Ages 3 to 65 years
Conditions the study is for
Thyroglossal Cyst
What is being tested?
The experimental group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
1 Sep 2026to 30 Jun 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 65 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • The cyst is in the non-acute infection stage;
  • The cyst has not ruptured to form a skin sinus tract or fistula;
  • Preoperative B-ultrasound and CT indicated that it was a thyroglossal duct cyst;
  • There are no severe underlying heart or lung diseases or coagulation dysfunction;
  • The patient and their family voluntarily chose to undergo laparoscopic resection of the thyroglossal duct cyst; ⑥ The patient and their family voluntarily signed the informed consent form.

Who cannot join

  • The cyst is in the acute infection stage;
  • The cyst ruptures, forming a skin sinus tract or fistula; ③ Has severe underlying heart and lung diseases and coagulation dysfunction; ④ Those with cyst diameters greater than 4 cm; ⑤ Those currently participating in other research studies.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Guang J Tang, MD contact

86+ 13595302195

tgjdoctor@163.com

About this study

Thyroglossal duct cysts are congenital diseases of the neck. Once detected, surgical treatment is the first choice. The traditional Sistrunk surgery has definite efficacy but leaves scars on the neck. With the popularization of the concept of minimally invasive surgery, the non-inflated submandibular approach endoscopic technique provides a new idea for achieving a scar-free resection of the neck. This project intends to conduct a randomized controlled study to scientifically evaluate the clinical efficacy and safety of submandibular approach endoscopic-assisted resection of thyroglossal duct cysts.

The study plans to include 60 newly diagnosed patients, randomly divided into the experimental group (submandibular approach endoscopic resection of thyroglossal duct cysts) and the control group (traditional open surgery). Systematically compare the perioperative indicators (operation time, intraoperative blood loss, average hospital stay), postoperative pain (VAS score), complications (infection, recurrence, injury of the sublingual nerve), and incision satisfaction (Vancouver Scar Scale) between the two groups.

This project is expected to establish a standardized surgical procedure, verify the superiority of this technique in achieving a scar-free neck while ensuring complete resection of the lesion, provide evidence-based medical evidence for the promotion of scar-free surgery in the neck, and have both clinical innovation and social benefits.

Read the detailed description
  1. Project-defined project goals and task requirements analysis 1.1 Project Goals 1.1.1 Overall Goal This project aims to conduct a prospective randomized controlled study to scientifically evaluate the clinical efficacy and safety of endoscopic-assisted thyroglossal duct cyst resection through an un-inflated submental approach, establish a standardized surgical procedure, and provide evidence-based medical evidence for the promotion of minimally invasive surgery with no neck scars.

1.1.2 Specific Goals 1.1.2.1 Efficacy Verification Goal Compare the differences in surgical time, intraoperative blood loss, hospital stay, and postoperative pain between the submental approach endoscopic surgery and the traditional Sistrunk surgery.

1.1.2.2 Safety Assessment Goal Monitor the incidence of complications and the 1-year recurrence rate of the two groups, ensuring that the recurrence rate of the observation group is controlled within 5% .

1.1.2.3 Aesthetic Effect Evaluation Goal Use the Vancouver Scar Scale (VSS) to evaluate the aesthetic appearance of the incision at 1, 3, and 6 months after surgery.

1.1.2.4 Technical Standardization Goal Summarize the key technical points and form a standardized surgical operation procedure.

1.2. Task Requirements Analysis 1.2.1 Clinical Requirements Thyroglossal duct cysts account for 75% of the spectrum of congenital diseases in the neck. Although the traditional Sistrunk surgery reduces the recurrence rate to below 5%, it leaves scars on the neck, causing psychological burden to patients. Therefore, a treatment plan that balances cure and aesthetics urgently needs to be established.

1.2.2 Technical Requirements The existing endoscopic approaches through the mouth, chest, and breast have high infection risks, large trauma range, and require inflation. The un-inflated submental approach utilizes the natural skin creases under the chin, has a short path, can directly handle the hyoid bone, and combines aesthetics with safety. However, it lacks large-sample randomized controlled studies for verification.

1.2.3 Evidence-Based Requirements Most existing studies are small-sample case reports and lack high-quality controlled studies [2]. Conducting rigorous randomized controlled trials to systematically compare the efficacy, safety, and aesthetic effects of the two surgical methods is an urgent need to promote clinical application.

1.2.4 Social Benefit Requirements Neck scars affect patients' self-confidence and quality of life. Achieving no-neck scars is an embodiment of the medical model's shift towards "physical and mental rehabilitation", with good social benefits and promotion prospects.

2 Project Objectives and Main Technical Difficulties and Issues in Task Resolution 2.1 Technical Difficulties in Laryngeal Bone Handling under Endoscopy 2.1.1 Description of the Difficulties The recurrence rate can be as high as 50% if the laryngeal bone is not handled thoroughly. Under the endoscopic view, the laryngeal bone is located deep within and has a hard texture. The primary difficulty is to precisely disarticulate it while avoiding damage to the hypoglossal nerve and the superior laryngeal nerve.

2.1.2 Solution Ideas Preoperative CT three-dimensional reconstruction is used to predict the resection range; during the operation, an ultrasonic bone knife is used for precise disarticulation; the "five-step method" is adopted as the standard operating procedure; intraoperative nerve monitoring is used to assist in protecting the nerves.

2.2 Narrow Operating Space and Difficulties in Field Exposure 2.2.1 Description of the Difficulties There are no natural cavities in the neck, and the small incision under the chin placed with the endoscope leads to the "chopstick effect". The cyst is located below the laryngeal bone, and the field exposure is difficult.

2.2.2 Solution Ideas The non-inflated suspension method is used to establish the operating space; specialized and elongated endoscopic instruments are modified; the suspension tension is dynamically adjusted; the indications are strictly selected, excluding cases with a diameter > 4 cm or those in the infectious stage.

2.3 Identification and Protection of Important Nerves and Blood Vessels 2.3.1 Description of the Difficulties The submandibular area involves the hypoglossal nerve, superior laryngeal nerve, etc. The identification is difficult under the two-dimensional endoscopic view, and incorrect injury can lead to serious complications.

2.3.2 Solution Ideas The nerve is located by using the digastric muscle and masseter muscle as references ; the surgical field is kept blood-free; postoperative close observation of swallowing and speech functions is conducted.

2.4 Learning Curve and Standardization of Surgical Procedure 2.4.1 Description of the Difficulties The surgeon needs to have both open surgery experience and endoscopic skills. The initial operation time is longer (median 135 minutes), and there is a possibility of conversion to open surgery.

2.4.2 Solution Ideas Conduct anatomical training and simulation operations; formulate standardized surgical procedures; initially operated by experienced physicians; regularly analyze and summarize to continuously optimize.

2.5 Objective Evaluation of Aesthetic Effect 2.5.1 Description of the Difficulties Scar evaluation is subjective. How to objectively quantify the aesthetic effect is a research design difficulty.

2.5.2 Solution Ideas The Vancouver Scar Scale (VSS) is used to score from four dimensions: color, thickness, vascular distribution, and softness; combined with patient satisfaction VAS evaluation; third-party blind assessment is conducted.

Being tested
The experimental group, In the control group
Keywords
Thyroglossal Cyst Submental approach Efficacy study
Medical subject headings
Thyroglossal Cyst

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The experimental groupProcedure or surgery

    Also called Submental endoscopic-assisted Sistrunk operation

    After general anesthesia, the patient is placed in the supine position with the neck slightly extended. A concealed transverse skin incision of approximately 2-3 cm is made about 1 cm below the chin (submental area), following the natural skin creases. Through this incision, blunt dissection is performed in the subplatysmal plane to create a subcutaneous tunnel reaching the hyoid bone region. The operation is assisted by an endoscope with a suspended retractor system without gas insufflation, thus avoiding the risk of gas embolism. Under high-definition endoscopic visualization, the thyroglossal duct cyst, the middle segment of the hyoid bone, and the track of the thyroglossal duct are meticulously dissected and completely resected en bloc. Hemostasis is achieved carefully to preserve the recurrent laryngeal and hypoglossal nerves. The wound is thoroughly irrigated with normal saline. A closed suction drain is placed if necessary. The submental incision is closed with intradermal absor

  • In the control groupOther

    Make an incision in the middle of the skin on the neck, cut through the skin and subcutaneous tissue, expose the tumor and the hyoid bone, and completely remove the thyroglossal

Study groups in NCT07778485
Study groupRoleWhat they receive
Submental endoscopic-assisted Sistrunk operationExperimentalAfter general anesthesia, the patient lies in a supine position with the neck slightly extended backward. A concealed incision of approximately 2-3 centimeters in length is made along the natural skin fold at about 1 centimeter below the chin (the submental area). Through this incision, a blunt dissection is performed at the subcutaneous thin muscle layer level to form a subcutaneous tunnel that extends directly to the thyroid cartilage region. The surgery is assisted by an endoscope with a suspension and traction system and without the need for inflation. Under high-definition endoscopic visualization, the thyroglossal duct cyst, the middle segment of the hyoid bone, and the path of the thyroglossal duct are carefully separated and completely resected. A closed drainage tube is placed. The submental incision is sutured using absorbable sutures within the dermis.
Receives: Other: In the control group
Conventional open Sistrunk operation via cervical incisionActive comparatorAfter general anesthesia, the patient is placed in the supine position with the neck extended. A horizontal skin incision is made along the midline of the neck directly over the thyroglossal duct cyst. The skin and subcutaneous tissues are divided. The strap muscles (sternohyoid and thyrohyoid) are separated in the midline to expose the cyst and the body of the hyoid bone. The thyroglossal duct cyst is dissected en bloc together with the central portion of the hyoid bone, preserving the surrounding vital structures. The surgical wound is thoroughly irrigated with normal saline. The incision is closed in layers with absorbable sutures, and a sterile dressing is applied.
Receives: Procedure: The experimental group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perioperative Clinical Indicators

    Includes operation time (minutes), intraoperative blood loss (mL), and postoperative length of hospital stay (days).

    Measured: Perioperative

  2. Vancouver Scar Scale (VSS) Score

    VSS evaluates scars across 4 subscales: pigmentation, thickness, vascularity, and pliability. Subscale scores are summed to generate a total score (range 0-15, with higher scores reflecting more severe scarring).

    Measured: up to 6 mouth

  3. Pain Intensity assessed by Visual Analogue Scale (VAS)

    A 10-cm horizontal line anchored by 0 (no pain) and 10 (worst imaginable pain). Participants mark a point corresponding to their current pain level. Higher scores indicate worse pain.

    Measured: up to 72 hours

Secondary outcomes (1)
  1. Total Postoperative Negative-Pressure Wound Drainage Volume

    Total volume (mL) of fluid collected from the surgical site via closed suction drainage prior to drain removal.

    Measured: up to Day 2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2026
  2. Study start1 Sep 2026 (estimated)
  3. Primary completion30 Jun 2028 (estimated)
  4. Study completion30 Jun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A prospective randomized controlled design was adopted. 60 patients with newly diagnosed primary thyroglossal duct cysts were planned to be included and randomly divided into the observation group and the control group, with 30 cases in each group. The experimental group would undergo a thyroid duct cyst resection surgery using the submental approach and laparoscopic assistance, while the control group would undergo the traditional Sistrunk open surgery. The perioperative indicators such as operation time, intraoperative blood loss, postoperative drainage volume, hospital stay, and postoperative visual analogue scale (VAS) score for pain were compared between the two groups. The results would be evaluated using statistics and the clinical application value of the minimally invasive surgical method would be comprehensively evaluated.
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07778485
Sponsor's protocol ID
PHAnshun2
Other IDs
An City Office [2026] No. 6
Status last verified
Aug 2026
First submitted
8 Jul 2026
Last updated
21 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Rohof D, Honings J, Theunisse HJ, Schutte HW, van den Hoogen FJ, van den Broek GB, Takes RP, Wijnen MH, Marres HA. Recurrences after thyroglossal duct cyst surgery: Results in 207 consecutive cases and review of the literature. Head Neck. 2015 Dec;37(12):1699-704. doi: 10.1002/hed.23817. Epub 2014 Sep 25.

    PubMed 24985922
  • Ellis PD, van Nostrand AW. The applied anatomy of thyroglossal tract remnants. Laryngoscope. 1977 May;87(5 Pt 1):765-70. doi: 10.1002/lary.5540870512.

    PubMed 850454
  • Sistrunk WE. THE SURGICAL TREATMENT OF CYSTS OF THE THYROGLOSSAL TRACT. Ann Surg. 1920 Feb;71(2):121-122.2. doi: 10.1097/00000658-192002000-00002. No abstract available.

    PubMed 17864229

Questions about this trial

What is this clinical trial studying?

A study testing The experimental group in people with Thyroglossal Cyst, run by People's Hospital of Anshun City of Guizhou Province.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Guang J Tang, MD (86+ 13595302195, tgjdoctor@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perioperative Clinical Indicators (time frame: Perioperative). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07778485, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in